Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Clinical Drug Investigation
|
August 13, 2016
Possible Digoxin-Azithromycin Interaction in a Child
P Miner
Alimentary Pharmacology & Therapeutics
|
October 22, 2004
Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment
P Miner
Journal of the South Carolina Medical Association (1975)
|
May 1, 1983
Chain saw injuries in South Carolina
T P McHugh, F P Miner
The American Journal of Gastroenterology
|
November 1, 1977
Pasteurella multocida bacteremia associated with peritonitis and cirrhosis
J A Jacobson, P Miner, O Duffy
Alimentary Pharmacology & Therapeutics
|
February 27, 2004
An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis
P Miner, M Wedel, B Bane, et al.
Digestive Diseases and Sciences
|
February 1, 1995
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group
P Miner, S Hanauer, M Robinson, et al.
Scandinavian Journal of Gastroenterology
|
October 16, 1999
Psychometric validation of a constipation symptom assessment questionnaire
L Frank, L Kleinman, C Farup, et al.
Alimentary Pharmacology & Therapeutics
|
February 6, 2010
Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn
P Miner, B Delemos, J Xiang, et al.
Alimentary Pharmacology & Therapeutics
|
May 25, 2010
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers
P Miner, J Plachetka, E Orlemans, et al.
Digestive Diseases and Sciences
|
April 16, 1998
Meal type affects heartburn severity
S Rodriguez, P Miner, M Robinson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Clinical Drug Investigation
|
August 13, 2016
Possible Digoxin-Azithromycin Interaction in a Child
P Miner
Alimentary Pharmacology & Therapeutics
|
October 22, 2004
Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment
P Miner
Journal of the South Carolina Medical Association (1975)
|
May 1, 1983
Chain saw injuries in South Carolina
T P McHugh, F P Miner
The American Journal of Gastroenterology
|
November 1, 1977
Pasteurella multocida bacteremia associated with peritonitis and cirrhosis
J A Jacobson, P Miner, O Duffy
Alimentary Pharmacology & Therapeutics
|
February 27, 2004
An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis
P Miner, M Wedel, B Bane, et al.
Digestive Diseases and Sciences
|
February 1, 1995
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group
P Miner, S Hanauer, M Robinson, et al.
Scandinavian Journal of Gastroenterology
|
October 16, 1999
Psychometric validation of a constipation symptom assessment questionnaire
L Frank, L Kleinman, C Farup, et al.
Alimentary Pharmacology & Therapeutics
|
February 6, 2010
Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn
P Miner, B Delemos, J Xiang, et al.
Alimentary Pharmacology & Therapeutics
|
May 25, 2010
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers
P Miner, J Plachetka, E Orlemans, et al.
Digestive Diseases and Sciences
|
April 16, 1998
Meal type affects heartburn severity
S Rodriguez, P Miner, M Robinson, et al.
Page
of 2